Independent directory Public ClinicalTrials.gov records United States
Clear filters

The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 4:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–183 of 183 matching trials from the local directory fallback.
Completed Not applicable Interventional Accepts healthy volunteers

Depression, Aging, Stress and Heart Health Study

NCT05570721
Conditions
Depression, Heart Disease in Women, Menopause, Stress
Interventions
Trier Social Stress Test
Behavioral
Lead sponsor
University of North Carolina, Chapel Hill
Other
Eligibility
44 Years to 55 Years · Female only
Enrollment
41 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2022 – 2025
U.S. locations
1
States / cities
Chapel Hill, North Carolina
Conditions
Heart Diseases
Interventions
Educational Intervention Alone, Ultrasound and Educational Intervention
Other
Lead sponsor
Rush University Medical Center
Other
Eligibility
45 Years and older
Enrollment
100 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2025 – 2026
U.S. locations
1
States / cities
Chicago, Illinois
Completed Not applicable Interventional Accepts healthy volunteers

Healthy Living Anson Study

NCT07126587
Conditions
Cancer, Diabetes Type 2, Heart Disease, High Cholesterol, Hypertension, Obesity (Disorder)
Interventions
Nutrition Education and Food Delivery, Physical Activity Comparator
Behavioral
Lead sponsor
University of North Carolina, Chapel Hill
Other
Eligibility
18 Years to 99 Years
Enrollment
44 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2025 – 2026
U.S. locations
1
States / cities
Chapel Hill, North Carolina
Conditions
Angina Pectoris, Cardiovascular Diseases, Heart Diseases, Microvascular Angina, Myocardial Ischemia, Vascular Diseases
Interventions
A-FLUX Reducer System
Device
Lead sponsor
VahatiCor, Inc.
Industry
Eligibility
18 Years and older
Enrollment
30 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2027
U.S. locations
3
States / cities
New Haven, Connecticut • Cincinnati, Ohio • Cleveland, Ohio
Terminated No phase listed Observational

A Cardiac Disease Quality of Life Study

NCT04080492
Conditions
Heart Disease Caused by Ionising Radiation, Hypertrophic Obstructive Cardiomyopathy, Quality of Life, Thoracic Aortic Dilatation
Interventions
QOL Survey
Other
Lead sponsor
The Cleveland Clinic
Other
Eligibility
18 Years to 70 Years
Enrollment
380 participants
Timeline
2019 – 2026
U.S. locations
1
States / cities
Cleveland, Ohio
Conditions
Blood Pressure, Blood Pressure Monitoring, Heart Disease, Hypertension (HTN)
Interventions
Model BB-613WP
Device
Lead sponsor
Biobeat Technologies Ltd.
Industry
Eligibility
18 Years and older
Enrollment
612 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2026
U.S. locations
6
States / cities
Birmingham, Alabama • Scottsdale, Arizona • Jacksonville, Florida + 3 more
Conditions
Heart Failure, Mitral Regurgitation, Valvular Heart Disease
Interventions
MitraClip, Moderate MR
Device · Other
Lead sponsor
Inova Health Care Services
Other
Eligibility
18 Years to 99 Years
Enrollment
33 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2026
U.S. locations
1
States / cities
Falls Church, Virginia
Conditions
Heart Diseases
Interventions
Group 1 (Intervention), Group 2 (Control)
Behavioral
Lead sponsor
Texas A&M University
Other
Eligibility
18 Years and older
Enrollment
2,420 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2023 – 2026
U.S. locations
13
States / cities
Camden, New York • Canastota, New York • Carthage, New York + 10 more
Conditions
Cardiovascular Diseases, Congestive Heart Failure, Heart Arrhythmia, Heart Disease, Ischemic, Heart Failure, Heart Failure, Diastolic, Heart Failure, Systolic, Heart Failure,Congestive, Heart; Complications
Interventions
3 x 10e13vg AB-1002
Biological
Lead sponsor
AskBio Inc
Industry
Eligibility
18 Years and older
Enrollment
11 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2026
U.S. locations
4
States / cities
Minneapolis, Minnesota • Cincinnati, Ohio • Columbus, Ohio + 1 more
Conditions
Complex Congenital Heart Disease, Congenital Heart Disease in Children, Hypoxia, Neurodevelopmental Disorders
Interventions
Neonatal Neurobehavioral Scale, Single Arm
Procedure
Lead sponsor
University of Utah
Other
Eligibility
0 Years to 52 Years · Female only
Enrollment
104 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2025
U.S. locations
5
States / cities
San Francisco, California • Washington D.C., District of Columbia • Scarborough, Maine + 1 more
Conditions
Fontan Physiology, Frailty, Single Ventricle Heart Disease
Interventions
HEART Club Home Exercise program - phase 2, WE BEAT Group Wellness Education program - phase 1
Behavioral
Lead sponsor
University of Michigan
Other
Eligibility
13 Years to 18 Years
Enrollment
30 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2022 – 2026
U.S. locations
1
States / cities
Ann Arbor, Michigan
Conditions
Atrial Fibrillation, Structural Heart Disease
Interventions
Echocardiogram, Zio Patch Monitor
Device
Lead sponsor
Tempus AI
Industry
Eligibility
40 Years and older
Enrollment
1,000 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2022 – 2025
U.S. locations
3
States / cities
Grand Rapids, Michigan • Cincinnati, Ohio • Danville, Pennsylvania
Conditions
Congenital Heart Disease
Interventions
passive range of motion exercise therapy
Other
Lead sponsor
Carelon Research
Other
Eligibility
Up to 35 Days
Enrollment
144 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2024
U.S. locations
9
States / cities
Atlanta, Georgia • Indianapolis, Indiana • Boston, Massachusetts + 6 more
Conditions
ALS, Age-Related Macular Degeneration, Allergies, Alopecia Areata, Alpha-Gal Syndrome, Alzheimer Disease, Amyloidosis, Ankylosing Spondylitis, Arthritis, Asthma, Atopic Dermatitis, Autism, Autoimmune Hepatitis, Behcet's Disease, Beta-Thalassemia, COPD, Cancer, Celiac Disease, Cirrhosis, Crohn Disease, Cystic Fibrosis, DMD, Diabetes, Dravet Syndrome, Fibromyalgia, Graves Disease, Heart Diseases, Hepatitis, Hidradenitis Suppurativa, ITP, Kidney Diseases, Leukemia, Lupus or SLE, Lymphoma, Multiple Sclerosis, Myasthenia Gravis, Parkinson Disease, Pemphigus Vulgaris, Psoriasis, Schizophrenia, Scleroderma, Sickle Cell Disease, Stroke, Thyroid Diseases, Ulcerative Colitis, Vasculitis, Vitiligo
Interventions
Specimen sample
Diagnostic Test
Lead sponsor
Sanguine Biosciences
Industry
Eligibility
18 Years to 85 Years
Enrollment
20,000 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2021 – 2025
U.S. locations
1
States / cities
Waltham, Massachusetts
Conditions
Congenital Heart Disease
Interventions
Whole Genome Sequencing (WGC) from subject samples
Diagnostic Test
Lead sponsor
Scripps Translational Science Institute
Other
Eligibility
18 Years and older · Female only
Enrollment
200 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2026
U.S. locations
1
States / cities
San Diego, California